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Abstract: Noninvasive coronary angiography has become an important imaging tool in the evaluation of patients with and 
at risk for coronary artery disease (CAD). Multidetector computed tomographic (MDCT) angiography offers excellent 
negative predictive value (95%) for the absence of coronary artery disease and has shown promising results in evaluating 
allograft vasculopathy, bypass grafts, and degenerative aortic valve disease. A single MDCT scan in the emergency de-
partment is valuable in ruling out both cardiac and noncardiac causes of acute chest pain. Cardiac magnetic resonance 
(MR) currently lacks the spatial resolution of MDCT limiting its assessment of the coronary vasculature, but the proximal 
coronary arteries can be evaluated along with myocardial function and viability without exposure to contrast dye or ioniz-
ing radiation. In addition, MR imaging also has great potential for characterizing coronary plaques, as well as following 
their progression and regression. 
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INTRODUCTION 
  Invasive coronary angiography is the gold standard for 
establishing the presence, location, and severity of coronary 
artery disease (CAD) [1,2]. While invasive coronary angi-
ography provides excellent spatial and temporal resolution 
for the visualization of the coronary arterial tree for catheter-
based or surgical interventions, this technique is invasive, 
costly [2] and associated with a small but definite risk of 
morbidity (1.5%) and mortality (0.15%) [3,4]. Therefore, a 
convenient, non-invasive alternative method for coronary 
angiography can provide significant clinical and economic 
benefits for most patients with and at risk for coronary artery 
stenosis [5].  
  Noninvasive cardiac imaging is evolving rapidly. Multi-
detector cardiac computed tomography (MDCT) and mag-
netic resonance (MR) imaging have become the preeminent 
modalities for the assessment of coronary artery atheroscle-
rosis. Once used primarily as research tools, these modalities 
are increasingly being used in routine clinical practice, par-
ticularly for direct imaging of the coronary vasculature. A 
review of the latest evidence is presented with respect to 
these evolving imaging modalities in the field of cardiology.
CORONARY CT ANGIOGRAPHY (FIGS. 1 AND 2) 
  Contemporary multislice/multidetector CT(MSCT/MDCT) 
techniques, which allow noninvasive evaluation of coronary 
arteries and bypass grafts, continue to evolve as alternatives 
to invasive coronary angiography. Modern MDCT systems 
can provide electrocardiogram-gated acquisition with ade-
quate temporal resolution (100-220ms) and the submillime-
ter spatial resolution needed to visualize the lumen of the 
coronary arteries. More recent modern dual source systems 
have even improved temporal resolution of 85 ms. Currently, 
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64-slice MDCT has a spatial resolution in the range of 0.6-
1.0 mm in all three dimensions (compared with 0.3 mm for 
conventional angiography). A spatial resolution of 1.0 mm is 
sufficient for imaging most of the coronary vascular tree, 
except for distal and calcified segments that require a spatial 
resolution of 0.5 mm [6].
  Numerous studies have evaluated the potential of CT 
coronary angiography to define focal coronary stenoses (Ta-
ble 1). MDCT has shown reliability for ruling out disease in 
nondiseased patients and is superior to MR for detecting 
significant atherosclerotic lesions [6]. In selected patients 
referred for invasive coronary angiography, the sensitivity of 
16- and 64-slice CT coronary angiography was 90% or 
higher in most studies after exclusion of arteries whose im-
age quality was considered to be subdiagnostic. 64-slice 
MDCT also has shown value in correctly identifying the 
absence of any atheromatous plaque among patients deemed 
to be at intermediate-to-high risk of CAD, with a negative 
predictive value >95% in most recent studies. In addition, as 
the number of detectors has increased, so has the number of 
coronary artery segments that can be evaluated. In a recent 
meta-analysis, 78%, 91%, and 100% of segments could be 
evaluated with an 8-, 16- and 64-slice MDCT, respectively 
[7].  
 Leschka  et al. [8] presented the first study exploring the 
diagnostic performance of 64-slice CT coronary angiogra-
phy. They evaluated all coronary segments 1.5 mm and re-
ported a high sensitivity and specificity for detecting signifi-
cant lesions. Their overall sensitivity for classifying stenoses 
was 94%, specificity was 97%, positive predictive value was 
87%, and negative predictive value was 99% [8]. Raff et al. 
[9] studied 70 consecutive patients, and found that of the 
1,065 coronary segments identified, 935 (88%) could be 
evaluated, and the specificity, sensitivity, and positive and 
negative predictive values for the presence of significant 
stenoses identified by 64-CT in comparison to CA were: by 
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by artery (n = 279), 91%, 92%, 80%, and 97%, respectively; 
by patient (n = 70), 95%, 90%, 93%, and 93%, respectively 
[9].  
  The CATSCAN trial [10], a multicenter 16-detector CT 
trial included eleven participating sites that prospectively 
enrolled 238 patients who were clinically referred for none-
mergency coronary angiography from June 2004 through 
March 2005. In their patient-based analysis, the sensitivity 
for detecting patients with at least 1 positive segment with 
>50% stenosis was 98%; specificity, 54%; positive predic-
tive value, 50%; and negative predictive value, 99%. More 
recently, results of the Coronary Evaluation Using Multi-
detector Spiral Computed Tomography Angiography using 
64 Detectors (CorE-64 trial) [11], the first multicenter trial 
assessing 64-detector CT scanning, reported a sensitivity of 
85% and a specificity of 90% compared with the gold-
standard of invasive angiography in a groups of 291 patients. 
  Although these applications of cardiac MDCT are prom-
ising, there is still room for improvement in coronary MDCT 
image acquisition and post-processing techniques. Current 
technological limitations still prevent exact quantification of 
the degree of stenosis and reliable visualization of all small 
A
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Fig. (2). (A) 64-slice MDCT curved multiplanar reformatted images 
from a 72 year old man with a history of coronary artery disease and 
hypercholesterolemia showing the left anterior descending artery 
with calcification and fatty plaque in its proximal to mid portion 
(shown in cross section in the inset images; L=lumen [~100 HU]; 
F=fatty plaque [40-70 HU]). Arrowheads denote areas of punctuate 
calcification (120-140 HU). 
(B) Curved multiplanar images from the same patient showing three 
patent coronary stents (arrowheads) as well as fatty plaques in the 
mid portion of the right coronary artery (shown in cross section in 
the inset image; L=lumen [~100 HU]; F=fatty plaque [40-50 HU]).  
A
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Fig. (1). 64-slice MDCT images of normal patient with heart rate of 
52 bpm (A), heart rate of 70 bpm (B), and obese patient with body 
mass index of 36 (C). Note in (A), the right coronary artery (RCA) 
is adequately evaluated in this oblique tomographic section. In (B),
misregistration artifacts due to suboptimal heart rate preclude ade-
quate visualization of the RCA, and in (C), adequate assessment of 
the RCA is precluded due to suboptimal imaging in an obese pa-
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Table 1.  Computed Tomographic Angiography of the Coronary Arteries 
Technique Reference  #  Patients  Sensitivity  Specificity 
Negative  
Predictive Value 
Nieman et al.
Circ 2002; 107: 664
59 86%  95%  97% 
Ropers et al.
Circ 2002; 107: 664
77 92%  93%  97% 
Mollet et al.
JACC 2004; 43: 
2265
128 95% 92% 98% 
Mollet et al.
JACC 2005; 45: 128
51 98%  95%  99% 
16-slice MDCT  
(segments >2mm)  
Hoffmann et al.
Circ 2004; 110: 
2638
103 98% 95% 99% 
Kuettner et al.
JACC 2004; 44: 
1230
60 97%  72%  97% 
Kuettner et al.
JACC 2005; 45: 123
72 92%  82%  97% 
Schuijf et al.
AJC 2005; 95: 571 
45 91%  93%  98% 
16-slice MDCT  
(all-segment analysis) 
Garcia et al. JAMA
2006; 296: 4 
238 89% 65% 99% 
Raff et al.
JACC 2005; 46: 552
84 86%  95%  98% 
Mollet et al.
Circ 2005; 112: 
2318
52 95%  99%  99% 
Leber et al.
JACC 2005; 47: 672
59 97%  80%  99% 
Leschka et al.
EHJ 2005; 26: 1482
67 97%  94%  99% 
Meijboom et al. 
JACC 2006; 48: 
1658
145 94% 98%  100% 
Ghostine et al. 
JACC 2006; 48: 
1929
66 72%  99%  97% 
Ong et al.AHJ
2006; 151: 1323 
134 80% 93% 94% 
Busch et al. Eur 
Radiol 2006  
25 82%  95%  95% 
Schuijf et al. JACC 
2006; 48: 2508  
114 85% 97% 90% 
64-slice MDCT 
Miller et al. AHA 
Scientific Sessions 
2007
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segments. In addition, image quality is compromised when 
the heart rate is too rapid, the patient is morbidly obese 
(>350 lbs), or the cardiac rhythm is irregular because of 
atrial fibrillation, frequent premature atrial or ventricular 
contractions, or exaggerated sinus arrhythmia. Importantly, 
MDCT detects significant CAD with excellent accuracy in 
patients with complete left-bundle branch block (LBBB) 
[12]. LBBB most commonly correlates strongly to age, asso-
ciated with atherosclerotic coronary artery disease, and in-
creases risk of cardiac mortality. Previously, non-invasive 
stress tests have limited performance in subjects with LBBB 
but MDCT is a robust tool to act as a filter in this setting to 
avoid unnecessary invasive diagnostic procedures [12]. 
  Also, calcium is a frequent feature of the coronary arter-
ies (found in 70-80% of the population), and complete as-
sessment by MDCT can be hindered by dense, focal calcium 
deposits in the vessel wall, leading to an overestimation of 
the severity of stenosis. With so-called “calcium blooming”, 
dense calcification often preclude assessment with MDCT 
and such lesions are common in patients with advanced 
CAD. Therefore, patient selection is crucial. 
  Finally, intravenous contrast and radiation limit the use 
of MDCT. The typical intravenous contrast dose is 70-100 
cc, and the usual radiation dose is 10-15 mSv [13]. The ra-
diation dose is equivalent to what is absorbed during a stress 
nuclear perfusion examination and nearly twice as high as 
conventional coronary angiography without ventriculogra-
phy or graft imaging. The risk of malignancy and other ra-
diation-related complications is uncertain with these doses, 
however researchers using dosimetry models have raised 
concerns regarding exposure [14]. Newer prospectively 
gated “step and shoot” methods have significantly decreased 
radiation dose by only turning the radiation tube on during a 
prespecified period of the cardiac cycle for vessel imaging at 
end diastole. This technique can bring radiation dose to lev-
els less that 5 mSv [15]. 
Of note, new directions are being explored as the MDCT 
technology matures. The 256- and 320-detector MDCT are 
currently under investigation. These newer scanners will 
obtain volumetric data with wide “whole-heart/single cardiac 
cycle” coverage in a single rotation and allow adequate visu-
alization of the cardiac chambers and coronary arteries by 
cine scan imaging. These characteristics are very promising 
with respect to solving many of the current limitations of 
MDCT including motion artifcats and misregistration band-
ing artifacts due to the inclusion of multiple cardiac cycles, 
and may provide a solution to the problems of current 
MDCT modality [16-20]. Kido et al. [16] showed the ability 
of the 256-detector row four-dimensional CT to assess coro-
nary arteries and cardiac function using data from a 1.5 s 
acquisition without the presence of any banding artifacts. 
Rybicki et al. [19] have reported their initial experience with 
320-detector cardiac CT. Their initial 320-detector row 
coronary CT images showed consistently excellent quality 
and iodinated contrast opacification.  
Specific Indications 
  Widespread use of MDCT in broad clinical populations 
without specific indications can lead to further unnecessary 
testing and escalating costs [21]. No official guidelines on 
the use of either modality for cardiac applications have been 
released but appropriateness criteria [22] have been pub-
lished as an intermediate step to avoid unnecessary and inap-
propriate testing. The appropriateness criteria focuses on 39 
CT and 33 MR indications identified by the panel as encom-
passing the majority of cases referred for each of the modali-
ties. Examples of highest-scoring indications included 
evaluation of intra- and extracardiac structures using cardiac 
CT or, in the case of suspected coronary anomalies, CT an-
giography. Lowest-scoring indications, given an "inappro-
priate" ranking, included evaluation of patients with a high 
pretest probability of CAD based on risk factors or results of 
other tests.  
  Limited information exists regarding the prevalence of 
clinically significant incidental unsuspected findings in pa-
tients undergoing MDCT. This technique frequently detects 
clinically occult and potentially life-threatening cardiac (eg. 
ventricular aneurysm, intramural thrombus) or noncardiac 
(eg. lung cancer) abnormalities and all physicians interpret-
ing MDCT should be cognizant of these finding. Lastly, 
long-term studies to determine the predictive prognostic 
value of MDCT are also necessary, similar to what has been 
done with electron-beam CT and coronary artery calcifica-
tion [23]. Still, several specific situations have emerged be-
yond simple coronary artery imaging in which MDCT may 
be particularly valuable. 
Bypass Graft Evaluation 
  Most early (<1 month) graft occlusion, which occurs in 
up to 10% of patients, is attributable to mechanical causes, 
whereas the late (5-10 years) stenosis or occlusion that oc-
curs in the majority of grafts results from an accelerated 
atherosclerotic process. Because many vein graft occlusions 
are asymptomatic, being able to identify early saphenous 
vein graft degeneration using CT coronary angiography may 
allow earlier intervention when graft patency makes revascu-
larization feasible. Bypass grafts are excellent targets for 
visualization with MDCT because of their reduced overall 
motion and their large lumens. Graft diameter typically 
ranges from 4 to 6 mm throughout the conduit, whereas the 
native vessel can taper to a diameter as small as 1 mm in the 
distal portion. However, limitations in the visualization of 
distal anastomosis sites and segments with adjacent clips 
exist. In a study by Schlosser et al., [24] MDCT showed 
good accuracy in assessing graft patency, with a sensitivity 
of 96% and a specificity of 95%. However, it was less well 
suited to evaluating areas adjacent to surgical clips and the 
distal bypass anastomosis could not be visualized in nearly 
25% of cases. Segments with adjacent clips can also be prob-
lematic. 
Cardiac Allograft Vasculopathy 
  Because noninvasive functional tests have traditionally 
lacked adequate sensitivity and specificity, conventional 
coronary angiography is the current gold standard for the 
serial detection and follow-up of cardiac allograft vasculopa-
thy in heart transplant patients. MDCT may offer a non-
invasive alternative. In a series of 53 patients who underwent 
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MDCT’s sensitivity and specificity for detecting coronary 
stenoses >50% were 83% and 95%, respectively [25]. It was 
felt that MSCT may offer an advantage over conventional 
coronary angiography by showing coronary wall thickening 
as well as luminal narrowing. visual assessment in this situa-
tion was noted to be limited by small caliber vessels, tachy-
cardia, and the presence of stents. 
Computed Tomography Scans for the Assessment of 
Chest Pain in the Emergency Department 
  The possibility of using MDCT for comprehensive as-
sessment of cardiac and noncardiac causes of chest pain in 
patients presenting to the emergency room is being evalu-
ated. In particular, a single MDCT scan could be used to rule 
out coronary artery disease, pulmonary embolism, and aortic 
dissection. A feasibility study of MDCT in evaluating car-
diac and noncardiac causes of acute chest pain in 69 patients 
presenting to the emergency department [26] showed that 
MDCT evaluation was comprehensive and produced a false-
negative rate of only 3%. Further investigation is needed to 
determine whether and how patients with low-to-interme-
diate risk can be triaged effectively using a MDCT algo-
rithm. 
 Goldstein  et al. [27] randomized patients presenting to 
the emergency department with acute chest pain to MDCT (n 
= 99) versus standard of care (n = 98). The MDCT patients 
with minimal disease were discharged; those with stenosis 
>70% underwent catheterization, whereas cases with inter-
mediate lesions or non-diagnostic scans underwent stress 
testing. Both approaches were found to be 100% safe. The 
MDCT alone immediately excluded or identified coronary 
disease as the source of chest pain in 75% of patients, includ-
ing 67 with normal coronary arteries and 8 with severe dis-
ease referred for invasive evaluation. The remaining 25% of 
patients required stress testing, owing to intermediate sever-
ity lesions or non-diagnostic scans. During the index visit, 
MDCT evaluation reduced diagnostic time compared with 
standard of care (3.4 h vs. 15.0 h, p < 0.001) and lowered 
costs ($1,586 vs. $1,872 p < 0.001). Further, MDCT patients 
required fewer repeat evaluations for recurrent chest pain 
(MDCT, 2 of 99 (2.0%) patients vs. no MDCT, 7 of 99 (7%) 
patients; p = 0.10) [27]. 
  This strategy of so-called “triple rule out” protocol (to 
exclude obstructive coronary artery disease, pulmonary em-
bolism, and aortic dissection simultaneously) in the emer-
gency room is currently investigated. Generally, these proto-
cols are not supported by the guidelines and remains “uncer-
tain” in the appropriateness criteria [22]. Further validation 
studies are needed to clarify whether patients can be appro-
priately discharged after negative initial enzyme test and/or 
no ST-segment changes [28]. 
Plaque Characterization (Fig. 2) 
  MDCT can provide valuable quantitative information on 
coronary atherosclerotic plaquesin an area of research. Spe-
cifically, based on plaque Hounsfield unit (HU) intensity, 
plaques may be categorized as calcified plaques (“hard”), 
fatty plaques (“soft”), fibrous plaques, or fibrofatty plaques. 
In terms of quantitative plaque volume measurement, its 
results correlate highly with those of intravascular ultrasono-
graphy [29,30]. In a recent study [29], 41 proximal coronary 
segments imaged using IVUS, sensitivity and specificity 
were 95% and 91%, respectively, for calcified plaque, and 
91% and 89%, respectively, for noncalcified plaque. Leber et
al. [30] studied 59 patients scheduled for invasive angiogra-
phy due to stable angina pectoris. A further subset of 18 pa-
tients had intravascular ultrasound (IVUS) of 32 vessels per-
formed as part of the catheterization procedure. The overall 
correlation between the degree of stenosis detected by quan-
titative coronary angiography compared with 64-CT was r = 
0.54. Sensitivity for the detection of stenosis <50%, stenosis 
>50%, and stenosis >75% was 79%, 73%, and 80%, respec-
tively, and specificity was 97%. In comparison with IVUS, 
46 of 55 (84%) lesions were identified correctly. Plaque and 
lumen areas derived by CT correlated well with IVUS, how-
ever, the results were limited by the insufficient ability of CT 
to exactly quantify the degree of stenosis despite excluding 
patients with atrial fibrillation, coronary artery calcification, 
stenting, and bypass surgery [30].  
  On the other hand, MDCT cannot yet provide specific 
qualitative plaque information obtained by MR imaging.CT 
differentiates plaque composition by Hounsfield unit value 
and there is a large overlap between plaque types (figure 2). 
In particular, differentiation between groups of fatty, fibrous, 
or fibrofatty plaques can be limited [31-33].  
CORONARY MR ANGIOGRAPHY (FIG. 3) 
  Cardiac MR allows assessment of proximal coronary 
anatomy, global and regional cardiac function, cardiac vol-
umes, and myocardial viability [34] without exposing pa-
tients to intravenous contrast or ionizing radiation. Individu-
ally, various cardiac MR techniques have shown promise as 
alternatives to established noninvasive tools for detecting 
coronary stenosis and myocardial infarction. Coronary MR 
angiography is still technically challenging for the assess-
ment of the presence and severity of coronary stenosis owing 
to small arterial size, tortuosity, complex anatomy, and car-
diac and respiratory motion.  
  Although there are limitations in the assessment of lumi-
nal stenosis, MR is highly efficacious for the evaluation of 
the course of anomalous coronary arteries. The relationship 
between the great vessels and the course of coronary arteries 
is better depicted by MR than by conventional coronary an-
giography because of the three-dimen-sional ability of MR in 
comparison with two-dimensional x-ray projections with 
overlapping structures. 
  Currently, coronary magnetic resonance angiography 
(MRA) sequences have resolutions on the order of 1.0 mm. 
The overall sensitivity and specificity of MRA is as high as 
90% for proximal and mid-coronary artery disease (Table 2). 
However, coronary MRA is used much less frequently than 
MDCT angiography to detect CAD because coronary MRA 
has a longer scan time and lower spatial resolution (1.2-1.4 
mm) than MDCT. Current MDCT technique offers the high-
est spatial resolution available for noninvasive coronary an-
giography, and the diagnostic performance of MDCT seems 
to be superior to that of MRI. The most promising MRA 
technique currently seems to be whole-heart acquisition, in 
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used in cardiac CT protocols [35]. Other methods that have 
been investigated include the use of intravascular gadolin-
ium-based agents and 3-dimensional acquisition strategies 
[36]. 
 Kim  et al. [37] performed the first multicenter trial where 
109 subjects were evaluated for CAD by the free-breathing 
3D technique. Lesions in the left main coronary artery in 
patients with three vessel disease could be identified with 
some certainty in a limited number of patients. A sensitivity 
of 83% was reported for this technique. However, this tech-
nique was limited to evaluation of proximal and middle seg-
ments only. In this study a total of 636 of 759 proximal and 
middle segments of coronary arteries were interpretable. The 
study also stated that major limitations with the 3D technique 
are the relatively longer time (average 70 minutes), low 
specificity (42%), and low overall diagnostic accuracy 
(72%).  
   Nikolaou et al. [38] evaluated 20 patients who had un-
Table 2.  Magnetic Resonance Angiography of the Coronary Arteries 
Technique Reference  #  Patients  Sensitivity  Specificity 
Manning et al.
NEJM 1993; 328: 828 
39 90% 92% 
Pennell et al.
Heart 1993; 70: 315 
30 85%  NA  2D breathhold 
Post et al.
EHJ 1997; 18: 426 
35 35% 63% 
Woodard et al.
AJR 1998; 170: 883 
10 70%  NA 
Kessler et al.
Radiology 1992; 210: 566 
73 65% 88% 
Sandstede et al.
AJR 1999; 172: 135 
30 81% 89% 
Sardanelli et al.
Radiology 2000; 214: 808 
42 82% 89% 
3D navigator, retrospective-
gating 
Kim et al. NEJM 2001; 345: 1863  109  83%  42% 
3D navigator, prospective-
gating 
Weber et al.
Eur Radiol 2002; 12: 718 
15 88% 94% 
Regenfus et al.
AJC 2002; 90: 725 
50 94% 57% 
Van Guens et al.
Radiology 2002; 217: 270 
38 68% 97% 
3D breathhold and/or contrast-
enhanced 
Nikolaou et al. Eur Radiol 2002; 12: 
1663
20 79% 70% 
A        B
Fig. (3). 3D breathhold and contrast-enhanced MR angiogram images of the left coronary artery (A) and the right coronary artery (B).Coronary Angiography Using Noninvasive Imaging Techniques  Current Cardiology Reviews, 2008, Vol. 4, No. 4    329
dergone contrast enhanced computed tomography (EBCT) 
and navigator echo-based coronary MRA with retrospective 
gating. The results were compared with conventional coro-
nary angiography. The sensitivity and specificity for detect-
ing significant stenoses with coronary MRA were 79% and 
70%, respectively, and with EBCT the sensitivity and speci-
ficity were 85% and 77%, respectively. The low sensitivity 
with 3D coronary MRA was attributed to inadequate syn-
chronization during the end-expiration phase [38].  
Plaque Characterization 
  Magnetic resonance imaging has technical limitations 
that make it more challenging for plaque volume measure-
ments, but it has great potential for noninvasive quality as-
sessment, using a variety of sequencing techniques (eg, T1, 
T2, fat saturation) [39,40]. In addition to being used to re-
search study atherosclerotic plaques in the human carotids 
and aorta [41], MR appears particularly promising for identi-
fying vulnerable coronary plaques [42]. Coronary arteries are 
relatively deeply located and create motion artifact, but in a 
study using a porcine model of CAD, MR imaging was 
found to sufficiently differentiate among fibrocellular, lipid-
rich, and calcified coronary plaques, and its findings corre-
lated with histopathologic findings [43]. For more precise 
quantification, contrast agents that target specific molecules 
(eg, adhesion molecules) or other substances are being de-
veloped [44,45]. In animal models, MR has also been a pow-
erful tool in serially investigating in vivo the progression and 
regression of atherosclerotic lesions [46]. Given the rapid 
development of this field, the ability to identify, aggressively 
treat, and serially monitor patients with high-risk plaques 
will probably improve significantly in the near future. 
CONCLUSION 
  Despite existing limitations, there is an important seg-
ment of the population in whom noninvasive imaging could 
provide coronary anatomic information with sufficient diag-
nostic quality. Furthermore, various noninvasive techniques 
offer potential advantages over traditional invasive coronary 
angiography, such as characterizing coronary plaque, provid-
ing both structural and functional information about the left 
ventricle and heart valves, and not exposing patients to the 
risk of vascular injury. On the horizon, combined CT and 
MR imaging may provide information not available from 
other imaging modalities, including lesion localization along 
with structural and biological plaque characterization.  
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